XML 14 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Apr. 30, 2013
Apr. 30, 2012
Apr. 30, 2013
Apr. 30, 2012
Net revenue:        
Product $ 121,188 $ 115,094 $ 366,498 $ 351,290
Engineering 4,577 6,176 17,688 14,270
Total net revenue 125,765 121,270 384,186 365,560
Cost of sales:        
Product 72,341 71,613 218,355 218,549
Engineering 4,284 4,905 16,206 12,388
Total cost of sales 76,625 76,518 234,561 230,937
Gross profit 49,140 44,752 149,625 134,623
Operating expenses:        
Research and product development 16,127 13,106 46,324 42,313
Selling and marketing 13,540 10,925 37,062 31,995
General and administrative 12,265 10,848 37,793 37,067
Restructuring 496   496  
Total operating expenses 42,428 34,879 121,675 111,375
Income from operations 6,712 9,873 27,950 23,248
Other income (expense):        
Interest income, net 76 98 284 367
Gain on sale of other investments       2,500
Other, net 114 325 (1,402) 822
Total other income (expense), net 190 [1] 423 [1] (1,118) [1] 3,689 [1]
Income before income taxes 6,902 10,296 26,832 26,937
Provision for (benefit from) income taxes 1,678 2,966 7,418 (4,034)
Net income $ 5,224 $ 7,330 $ 19,414 $ 30,971
Net income per common share:        
Basic $ 0.42 $ 0.60 $ 1.58 $ 2.48
Diluted $ 0.41 $ 0.59 $ 1.54 $ 2.45
Weighted average shares outstanding:        
Basic 12,305 12,227 12,300 12,470
Diluted 12,620 12,433 12,584 12,636
Dividends declared and paid per share: $ 0.10 $ 0.10 $ 0.30 $ 0.30
[1] Includes a gain of $2,500 from the sale of our remaining interest in our China based affiliate received in the nine months ended April 30, 2012.